Dennis Fournogerakis advises life sciences companies on sales force sizing and deployment, portfolio optimization, targeting, market assessment and forecasting, and incentive compensation. He is particularly skilled in leading successful commercialization strategies for oncology therapies and orphan drugs. He was named a PM360 ELITE 2020 “Leader of the Future.” Dennis joined the firm in 2013 after earning a doctorate in chemistry from Stanford University and bachelor’s degree in chemistry from the University of Wisconsin-Madison.
